MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

Search

Pfizer

Cerrado

SectorSanidad

23 -5.39

Resumen

Variación precio

24h

Actual

Mínimo

22.95

Máximo

23.19

Métricas clave

By Trading Economics

Ingresos

-4.1B

411M

Ventas

63M

18B

P/B

Media del Sector

17.972

63.778

BPA

0.63

Rentabilidad por dividendo

6.79

Margen de beneficios

2.314

Empleados

81,000

EBITDA

-4.3B

2.5B

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+32.96% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

6.79%

2.39%

Próximas Ganancias

29 abr 2025

Fecha Próximo Dividendo

13 jun 2025

Próxima Fecha de Ex Dividendo

8 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-7.5B

144B

Apertura anterior

28.39

Cierre anterior

23

Noticias sobre sentimiento de mercado

By Acuity

70%

30%

351 / 386 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bearish Evidence

Pfizer Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

19 mar 2025, 07:34 UTC

Adquisiciones, fusiones, absorciones

Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion

18 mar 2025, 17:26 UTC

Adquisiciones, fusiones, absorciones

Pfizer to Dispose of Remaining Shareholding in Haleon

4 feb 2025, 18:52 UTC

Principales Movimientos del Mercado

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

4 feb 2025, 14:58 UTC

Ganancias
Principales Movimientos del Mercado

Pfizer Shares Rise on Better-Than-Expected 4Q

26 mar 2025, 22:29 UTC

Principales Noticias

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- 2nd Update

26 mar 2025, 19:19 UTC

Principales Noticias

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- Update

26 mar 2025, 17:39 UTC

Principales Noticias

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- WSJ

18 mar 2025, 16:58 UTC

Adquisiciones, fusiones, absorciones

Haleon Intends to Cancel Purchased Ordinary Shares

18 mar 2025, 16:57 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Off-Market Transaction Will Close at Same Time as or Following Settlement of Offering

18 mar 2025, 16:56 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Off-Market Purchase Worth Approx GBP170M in Ordinary Shares

18 mar 2025, 16:56 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Haleon Agreed to Carry out Off-Market Purchase From Pfizer

18 mar 2025, 16:52 UTC

Adquisiciones, fusiones, absorciones

Haleon Takes Note of Announcement

18 mar 2025, 16:50 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Haleon Won't Receive Any Net Proceeds From Offering

18 mar 2025, 16:50 UTC

Adquisiciones, fusiones, absorciones

Citigroup: This Is Subject to Customary Closing Conditions

18 mar 2025, 16:50 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Pfizer Will Receive All of Net Proceeds From Offering

18 mar 2025, 16:49 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Bookbuilding Period May Close at Any Time on Short Notice

18 mar 2025, 16:49 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Bookbuilding Period Will Commence Immediately

18 mar 2025, 16:49 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Price Per Sale Share to Be Determined Through Accelerated Bookbuilding Process

18 mar 2025, 16:48 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Pfizer Intends to Sell Ordinary Shares to Institutional Investors

18 mar 2025, 16:47 UTC

Adquisiciones, fusiones, absorciones

Citigroup:: Amount Is Pfizer's Entire Residual Shareholding in Haleon

18 mar 2025, 16:47 UTC

Adquisiciones, fusiones, absorciones

Citigroup: This Represents Approx 7.3% Stake in Haleon

18 mar 2025, 16:46 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Pfizer Intends to Sell Approx 662M Ordinary Shares in Haleon

17 mar 2025, 09:00 UTC

Principales Noticias

Pfizer Has a New Playbook for Reviving Sales -- And It's Starting to Pay Off -- WSJ

28 feb 2025, 12:00 UTC

Principales Noticias

Drug Stocks Are the New Safe Bet in a Shaky Market -- Heard on the Street -- WSJ

14 feb 2025, 11:38 UTC

Principales Noticias
Ganancias

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

14 feb 2025, 11:30 UTC

Principales Noticias
Ganancias

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

5 feb 2025, 12:00 UTC

Principales Noticias

Merck Is Suffering From a Classic Pharma Problem -- Heard on the Street -- WSJ

4 feb 2025, 19:34 UTC

Principales Noticias

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 3rd Update

4 feb 2025, 19:10 UTC

Principales Noticias

Pfizer Falls on RFK's Progress Towards Confirmation Despite Good Earnings. Its CEO is Unbothered. -- Barrons.com

4 feb 2025, 18:51 UTC

Principales Noticias

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 2nd Update

Comparación entre iguales

Cambio de precio

Pfizer previsión

Precio Objetivo

By TipRanks

32.96% repunte

Estimación a 12 Meses

Media 30.54 USD  32.96%

Máximo 36 USD

Mínimo 27 USD

De acuerdo con 15 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Pfizer Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

15 ratings

6

Comprar

9

Mantener

0

Vender

Puntuación técnica

By Trading Central

N/A / 25.23Soporte y Resistencia

Corto Plazo

Weak Bearish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

351 / 386 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.